A Novel NF-κB Pathway Involving IKKβ and p65/RelA Ser-536 Phosphorylation Results in p53 Inhibition in the Absence of NF-κB Transcriptional Activity

• Published in: The Journal of biological chemistry 2005-03, Vol.280 (11), p.10326-10332
• Main Authors: Jeong, Soo-Jin, Pise-Masison, Cynthia A., Radonovich, Michael F., Park, Hyeon Ung, Brady, John N.
• Format: Article
• Language: English
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M412643200

Nuclear factor κB (NF-κB) plays an important role in regulating cellular transformation and apoptosis. The human T-cell lymphotropic virus type I protein, Tax, which is critical for viral transformation, modulates the transcription of several cellular genes through activation of NF-κB. We have demonstrated previously that Tax inhibits p53 activity through the p65/RelA subunit of NF-κB. We now present evidence that suggests that the upstream kinase IKKβ plays an important role in Tax-induced p53 inhibition through phosphorylation of p65/RelA at Ser-536. First, mouse embryo fibroblast (MEF) IKKβ–/–cells did not support Tax-mediated p53 inhibition, whereas MEFs lacking IKKα allowed Tax inhibition of p53. Second, transfection of IKKβ wild type (WT), but not a kinase-dead mutant, into IKKβ–/–cells rescued p53 inhibition by Tax. Third, the IKKβ-specific inhibitor SC-514 decreased the ability of Tax to inhibit p53. Fourth, we show that phosphorylation of p65/RelA at Ser-536 is important for Tax inhibition of p53 using MEF p65/RelA–/–cells transfected with p65/RelA WT or mutant plasmids. Moreover, Tax induced p65/RelA Ser-536 phosphorylation in WT or IKKα–/– cells but failed to induce the phosphorylation of p65/RelA Ser-536 in IKKβ–/–cells, suggesting a link between IKKβ and p65/RelA phosphorylation. Consistent with this observation, blocking IKKβ kinase activity by SC-514 decreases the phosphorylation of p65/RelA at Ser-536 in the presence of Tax in human T-cell lymphotropic virus type I-transformed cells. Finally, the ability of Tax to inhibit p53 is distinguished from the NF-κB transcription activation pathway. Our work, therefore, describes a novel Tax-NF-κB p65/RelA pathway that functions to inhibit p53 but does not require NF-κB transcription activity.